| Primary |
| Hypertension |
56.3% |
| Cardiac Failure |
8.6% |
| Angina Pectoris |
5.9% |
| Diabetes Mellitus |
5.4% |
| Hyperlipidaemia |
4.1% |
| Essential Hypertension |
2.3% |
| Constipation |
1.8% |
| Primary Hyperaldosteronism |
1.8% |
| Atrial Fibrillation |
1.4% |
| Cardiac Failure Chronic |
1.4% |
| Dyslipidaemia |
1.4% |
| General Anaesthesia |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Lumbar Spinal Stenosis |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Arteriosclerosis Coronary Artery |
0.9% |
| Blood Aldosterone Increased |
0.9% |
| Cerebral Infarction |
0.9% |
| Diverticulitis |
0.9% |
| Gastric Ulcer |
0.9% |
|
| Interstitial Lung Disease |
12.9% |
| Hyperkalaemia |
10.0% |
| Aspartate Aminotransferase Increased |
8.6% |
| Blood Creatine Phosphokinase Increased |
7.1% |
| Diabetes Mellitus |
5.7% |
| Fracture |
5.7% |
| Hepatic Function Abnormal |
5.7% |
| Rhabdomyolysis |
5.7% |
| Cholecystitis |
4.3% |
| Hypercalcaemia |
4.3% |
| Urinary Incontinence |
4.3% |
| Anaemia |
2.9% |
| Blood Alkaline Phosphatase Increased |
2.9% |
| Cardiac Arrest |
2.9% |
| Haemolytic Anaemia |
2.9% |
| Haemorrhage Subcutaneous |
2.9% |
| Hypokalaemia |
2.9% |
| Hyponatraemia |
2.9% |
| Infection |
2.9% |
| Iris Atrophy |
2.9% |
|
| Secondary |
| Hypertension |
25.9% |
| Cardiac Failure |
11.4% |
| Product Used For Unknown Indication |
9.6% |
| Angina Pectoris |
7.8% |
| Atrial Fibrillation |
7.2% |
| Diabetes Mellitus |
6.6% |
| Pulmonary Hypertension |
6.0% |
| Cardiac Failure Chronic |
5.4% |
| Dyslipidaemia |
3.0% |
| Arteriosclerosis Coronary Artery |
2.4% |
| Constipation |
2.4% |
| Right Ventricular Failure |
2.4% |
| Lumbar Spinal Stenosis |
1.8% |
| Tachycardia |
1.8% |
| Hypercholesterolaemia |
1.2% |
| Hyperlipidaemia |
1.2% |
| Insomnia |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
| Asthma |
0.6% |
| Coronary Arterial Stent Insertion |
0.6% |
|
| Diabetes Mellitus |
11.4% |
| Nasopharyngitis |
8.6% |
| Renal Failure Acute |
8.6% |
| Ventricular Tachycardia |
8.6% |
| Blood Creatine Phosphokinase Increased |
5.7% |
| Hyperkalaemia |
5.7% |
| Lacunar Infarction |
5.7% |
| Metabolic Encephalopathy |
5.7% |
| Renal Failure Chronic |
5.7% |
| Transient Ischaemic Attack |
5.7% |
| Blood Alkaline Phosphatase Increased |
2.9% |
| Cardiac Arrest |
2.9% |
| Cardiac Disorder |
2.9% |
| Cardiac Failure |
2.9% |
| Dehydration |
2.9% |
| Hepatic Function Abnormal |
2.9% |
| Hyponatraemia |
2.9% |
| Infection |
2.9% |
| Interstitial Lung Disease |
2.9% |
| Restlessness |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.9% |
| Hypertension |
20.6% |
| Cardiac Failure |
10.8% |
| Gastritis Atrophic |
4.9% |
| Chronic Hepatitis C |
4.0% |
| Conjunctivitis Allergic |
3.8% |
| Diabetes Mellitus |
3.8% |
| Prostate Cancer |
3.8% |
| Prophylaxis |
3.7% |
| Lumbar Spinal Stenosis |
3.5% |
| Cardiac Failure Chronic |
2.9% |
| Constipation |
2.2% |
| Intervertebral Disc Protrusion |
2.2% |
| Atrial Fibrillation |
2.1% |
| Benign Prostatic Hyperplasia |
1.6% |
| Hyperaldosteronism |
1.6% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.6% |
| Fluid Retention |
1.4% |
| Insomnia |
1.4% |
| Dysuria |
1.3% |
|
| Prinzmetal Angina |
10.9% |
| Platelet Count Decreased |
9.1% |
| Cerebral Infarction |
7.3% |
| Renal Impairment |
7.3% |
| Pruritus |
5.5% |
| Renal Failure |
5.5% |
| Sudden Death |
5.5% |
| Vomiting |
5.5% |
| Anaphylactic Shock |
3.6% |
| Cholangitis Acute |
3.6% |
| Diarrhoea |
3.6% |
| Eosinophil Count Increased |
3.6% |
| Eosinophilic Pneumonia |
3.6% |
| Hepatic Function Abnormal |
3.6% |
| Hypoglycaemia |
3.6% |
| Lung Disorder |
3.6% |
| Malaise |
3.6% |
| Off Label Use |
3.6% |
| Overdose |
3.6% |
| Rash Generalised |
3.6% |
|
| Interacting |
|
|
